Clinical Trial Update: Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of the RD regimen (lenalidomide plus dexamethasone) for Rosai-Dorfman disease; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosai-dorfman Disease

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Rosai-Dorfman Disease | Phase 2 | Status: RECRUITING